Last reviewed · How we verify
HN2301 injection
At a glance
| Generic name | HN2301 injection |
|---|---|
| Also known as | in vivo cart |
| Sponsor | Shenzhen MagicRNA Biotechnology Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs） (NA)
- Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |